The "Nebulizer Patent Landscape Report" report has been added to ResearchAndMarkets.com's offering. A comprehensive analysis ...

An inhaled gene therapy for cystic fibrosis developed by Boehringer Ingelheim is due to start clinical testing shortly, ...

Blincyto's label has gradually been extended since 2014, and in December the MHRA approved it as the first immunotherapy for ...

BMS' Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.

Shares of Amgen Inc. AMGN advanced 1.24% to $297.93 Thursday, on what proved to be an all-around dismal trading session for ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Cancer diagnoses tended to arise more in patients who bled on oral anticoagulants (OACs), a Canadian population-based cohort ...

During a live event, Alexander I. Spira, MD, PhD, and participants NGS testing practices and the rationale behind their ...

Pembrolizumab is a checkpoint inhibitor that binds to the protein PD-1 on T cells to help them recognize and attack invaders.